No Detail Found!

Commodifying vaccines to curtail antibiotic resistance impact in malaria endemic countries

Author(s)
Maria Khan Department of Microbiology, Peshawar Institute of Cardiology-MTI,Peshawar,Pakistan
Abstract
Rampant and prevalent deployment of an e cient malaria vaccine in Pakistan, together with basic control and preventive measures, could signi cantly decrease the economic and healthcare burden caused by drug-resistant malaria.Moreover, RTS, S/AS01 vaccine has attained a much-needed breakthrough after decades of growth, as an innovative vaccine for malaria in Phase III clinical trials, and presently undergoing implementation studies. So far Gavi, WHO, and other stakeholders are contemplating on the practical issues, riskbene t, and cost-e ectiveness in resource-limited settings of vaccine implementation capacity. Imminent advances, like using a delayed as well as enhanced protection, divided schedule for dosing, and alternate adjuvants are likely to attain the vital goal of eradication of malaria. Vaccination is a potentially critical component of e orts to arrest the development and dissemination of antimicrobial resistance; though little is known about the impact vaccination may have within low-and-middle-income countries.
Publication Details
Page(s) 1454-1456
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 12, Year: 2023

Request the full text from PASTIC

Keywords
malaria, Vaccine, Antimicrobial resistance
0

Citations

0

Downloads

137

Views